News & Trending Investing News

This Under-the-Radar Stock Could Be the Next Big Split - And Early Investors Could Win Big

Why Eli Lilly's soaring share price has investors watching for a potential 2026 stock split.

By Jordan Major

Edited by Laura Hohenstein

Updated March 5, 2026

Add Us On Google

Eli Lilly (LLY) is quietly emerging as one of the most talked-about stock split candidates for 2026, and that's not just because of headlines.

Analysts point to its elevated share price as a barrier for many retail investors looking to make money, which often precedes a split in large, successful companies when management wants to make shares more accessible and boost liquidity.

Get a protection plan on all your appliances

Did you know if your air conditioner stops working, your homeowner’s insurance won’t cover it? Same with plumbing, electrical issues, appliances, and more.

Whether or not you’re a new homeowner, a home warranty from Choice Home Warranty could pick up the slack where insurance falls short and protect you against surprise expenses. If a covered system in your home breaks, you can call their hotline 24/7 to get it repaired.

For a limited time, you can get your first month free with a Single Payment home warranty plan.

Get a free quote

What Eli Lilly does and why it's grown

Eli Lilly and Company is one of the largest pharmaceutical firms in the world, with a history stretching back to 1876. It develops and sells medicines globally, with especially strong momentum in diabetes, obesity, and other high-growth therapeutic markets. Its GLP-1 and related drug portfolio has driven rapid revenue expansion and established Lilly as a top healthcare name for long-term investors.

Over the past several years, the stock has delivered eye-catching returns. Trading around $1,030 as of late February, 2026, LLY shares have climbed roughly 48% over the past six months, about 14% in the past year, and an impressive over 400% across the past five years.

Put differently, Eli Lilly stock has risen roughly fivefold from around $204 five years ago. However, year-to-date, shares have dipped slightly, a reminder that even standout stocks don't move in a straight line.

Who really has the cheapest auto insurance in your area? Check your zip code here.

Has Eli Lilly split its stock before?

Eli Lilly has split its stock multiple times in the past, most recently in 1997. Like many long-running blue-chip companies, it used splits during periods of strong growth to keep its share price more accessible to investors.

While past splits don't guarantee future ones, they do show that the company has used this strategy before. With shares now trading above $1,000, some analysts believe management may consider a similar move if the price continues to climb.

What is a stock split?

A stock split is a corporate action that increases the number of shares outstanding while proportionally lowering the trading price per share. For example, in a 2-for-1 split, shareholders receive one extra share for every share they own, while the share price is cut roughly in half. Importantly, a split does not change a company's market capitalization or fundamentals on the day it happens.

So why do companies do it? Most often, splits make a high-priced stock more affordable for a broader base of retail investors and can boost trading liquidity. They can also signal confidence from management about future growth prospects. That's why a stock like Eli Lilly, with a price north of $1,000, ends up on lists of potential 2026 split candidates.

How a split could impact investors

A stock split doesn't improve revenue, earnings, or a company's competitive position overnight. What it can change is investor behavior.

When a stock's price drops after a split, even though the company's value stays the same, shares often feel more accessible. A lower trading price can make it easier for individual investors to buy whole shares, even in a world where fractional trading is common.

Splits can also create a psychological boost. They tend to generate renewed investor interest and media attention, which can sometimes support positive price momentum.

And timing matters. Investors who buy before a split could benefit not only from any potential post-split enthusiasm but also from simply having more time invested in the company's long-term growth story. In the market, time can be just as powerful as timing.

Why early investors could benefit

Being an early investor before a rumored split can be advantageous because you're positioned for both the core long-term growth and any additional upside that may come from broader retail participation or heightened attention once a split is announced.

For example, stocks that split often continue their growth trajectories afterward, partly because a split does not change fundamentals but can remove a barrier that kept some buyers on the sidelines.

Analyst sentiment also reflects continued optimism. BofA Securities at the end of February reiterated a Buy rating on Eli Lilly and set a $1,293 price target over the next 12 months, which represents roughly 25% upside from current levels.

Of course, price targets are not guaranteed. But for investors who believe in the company's long-term growth story, entering before a potential split could mean more time in the market and exposure to both business expansion and any renewed interest that a split might generate.

Considerations before you invest

Before investing in Eli Lilly purely because of stock split speculation, it's important to step back and look at the bigger picture.

First, don't chase a rumor. A split is not guaranteed. As of early 2026, the company has not announced one, and any decision would ultimately come from its board. Speculation alone isn't a solid investment thesis.

It's also important to understand the business itself. Lilly's recent growth has been driven largely by strong demand for its drug portfolio, particularly in high-growth treatment areas.

That momentum has supported rising earnings and upbeat guidance, which is one reason analysts have lifted price targets. At the same time, pharmaceutical companies operate in a competitive and heavily regulated environment, and pricing pressure can affect future results.

Finally, valuation and risk deserve careful attention. High-growth stocks often trade at premium valuations, which can lead to volatility if expectations shift. Before buying, make sure the stock aligns with your broader investment strategy, time horizon, and risk tolerance.

Bottom line

Eli Lilly is attracting attention as a potential 2026 stock split candidate thanks to its high share price and strong performance over the past several years. A split could lower LLY's trading price per share and make the stock more accessible to a larger group of investors, while early buyers benefit from longer exposure to the company's growth story.

But remember: a split is a corporate action, not a business driver. Smart investing still starts with understanding the company's fundamentals, market position, and maintaining strong financial fitness.

More from FinanceBuzz:

Help Protect Your Savings From Stock Market Volatility With Gold

American Hartford Gold Benefits

American Hartford Gold helps individuals protect their retirement by rolling over IRAs and 401(k)s into physical gold.
Includes FREE IRA rollover and storage for up to 3 years.
Get up to $20,000 in free silver on qualifying purchases.

Download your guide for free